Status:

NOT_YET_RECRUITING

Short Term Reproducibility of Office White-coat Effect

Lead Sponsor:

University Hospital, Caen

Conditions:

White Coat Hypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

While a theoretical increase in systolic blood pressure (BP) of 10 mmHg can triple the relative risk of cardiovascular disease (CVD), the potential presence of a white coat effect (WCE) can interfere ...

Eligibility Criteria

Inclusion

  • adult patients ;
  • not taking any antihypertensive medication;
  • free of any cardiovascular pathology.

Exclusion

  • patients who are minors or protected adults ;
  • patients with BP ≥160/105 mmHg;
  • history of secondary hypertension;
  • taking a treatment that may affect blood pressure.

Key Trial Info

Start Date :

September 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2025

Estimated Enrollment :

922 Patients enrolled

Trial Details

Trial ID

NCT06523062

Start Date

September 1 2024

End Date

August 31 2025

Last Update

July 26 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.